Uncertain diagnosis and prognosis in advanced melanoma: a qualitative study of the experiences of bereaved carers in a time of immune and targeted therapies

Abstract

Summary Background Recent advances in advanced melanoma therapies are associated with improved survival for some patients. However, how patients with diagnoses of advanced disease and their carers experience this expanding treatment paradigm is not well understood. Objectives To explore bereaved carers’ accounts of the trajectory of advanced melanoma involving treatment by immune or targeted therapies, to build an understanding of their experiences of care relating to diagnosis and prognosis. Methods A qualitative exploratory design, using methods drawn from grounded theory, was adopted. Analyses drew on in‐depth interviews with 20 bereaved carers from three metropolitan melanoma treatment centres in Australia. A flexible interview guide and structured approach to concurrent data collection and analysis were applied. Results Carers described qualities of the experience, including the shock of diagnosis after a sometimes‐innocuous presentation with vague symptoms. They reported an unclear prognosis with complexity arising from interplay between an uncertain disease trajectory and often ambiguous expectations of outcomes of emerging immune and targeted therapies. Uncertainty dominated carers’ experiences, increasing the complexity of care planning. Conclusions Effective communication of an advanced melanoma diagnosis and prognosis is critical. Recognition of the uncertainty inherent in the benefit of immune and targeted therapies in a constructive manner may facilitate more timely and effective care‐planning conversations between patients, carers and medical specialists.

Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol

“…24 47 Indeed, patients reported feeling hampered by a lack of clear information, 23 and carers experienced unclear communication regarding immunotherapy treatment. 47 Findings from a recent study 48 indicated that most recommendations for ICI treatment were made by physicians, though patients generally preferred to have the final say regarding treatment commencement. Further enquiry is therefore required to explore both patients' and healthcare professionals' experiences of immunotherapy treatment decision-making in the context of the UK.…”

Palliative care in the context of immune and targeted therapies: A qualitative study of bereaved carers’ experiences in metastatic melanoma

“…21 Patients/carers and clinicians navigate a complex disease trajectory 22 and face ongoing uncertainty regarding prognosis, progression, treatment and possible outcomes. 8,23 Uncertainty adds to healthcare system fragmentation and lack of coordination. 6,24,25 Previously, therapeutic and end-of-life discussions concerning metastatic melanoma were framed around poor prognosis.…”

Take 10: ten qualitative studies on under‐researched groups and hard‐to‐reach issues in dermatology

“…Authors responded to our challenge with a wider range of submissions and almost double the number submitted last time, showing the growing interest in qualitative research in this field. Our second spotlight for summer 2019 showcases 10 studies, comprising a complementary mix of six original articles and four research letters . These papers involve interdisciplinary authorship teams from dermatology, psychology, general practice, nursing, public health and applied health services research in Australia, Germany, the Netherlands, the Republic of Ireland, the U.K. and the U.S.A.…”

“…Six papers, demonstrate qualitative methods’ capacity to access psychological and social issues that are difficult to reach with traditional questionnaire/survey research, and the capability to investigate the portrayal and experience of the skin in the online world. Fox et al . explored the unique perspective of carers on their journey through advanced melanoma diagnosis, death and bereavement.…”

“…Six papers, 7-10,12,13 demonstrate qualitative methods' capacity to access psychological and social issues that are difficult to reach with traditional questionnaire/survey research, and the capability to investigate the portrayal and experience of the skin in the online world. Fox et al 7 explored the unique perspective of carers on their journey through advanced melanoma diagnosis, death and bereavement. In-depth interviews with grounded theory explored this sensitive topic to reveal the ongoing uncertainty of disease progression, treatment and outcomes, compounded by unclear expectations of emerging immune and targeted therapies.…”